ICAAC 45th

Drupal spam blocked by CleanTalk.
Title Content type
In Vitro Activity of the New Azole BAL4815 against Clinical Candida Isolates Comprising Resistant C. albicans and Less Susceptible Candida spp (click for details)
Efficacy, Safety, and Tolerability of three Different Dosing Regimens of BAL8557 Vs. Fluconazole in a Double-Blind, Randomized, Multicenter Trial for the Treatment of Esophageal Candidiasis in Immunocompromised Adults (click for details)
In vivo Efficacy of the triazole BAL8557 (BAL) Compared to Voriconazole (VOR), Itraconazole (ITC) and Caspofungin (CAS) By a New qPCR and Quantitative Culture in a Neutropenic Murine Model of Aspergillus flavus (click for details)
Dose Response Curves and Dose Fractionation Studies with BAL8557 in a Murine Model of Disseminated Candidiasis (click for details)
Antifungal Activity of BAL4815, a Novel Azole Against Dermatophytes and Emerging Non-Dermatophyte Fungi Including Zygomycetes (click for details)
In vitro activity of the new azole BAL4815 against clinical dermatophyte isolates (click for details)
Posaconazole (POS) as Salvage Therapy in Patients with Invasive Fungal Infections (IFIs) Following Solid-Organ Transplant (SOT) (click for details)
The Unique Alternative Mitochondria Pathway of C. parapsilosis and reduced In Vitro Susceptibility to Caspofungin (CAS) (click for details)
Risk Factors (RF), Treatment (TX), Health and Economic Outcomes in Patients (PT) with Candidemia (click for details)
Efficacy of Aminocandin (IP960), Micafungin and Caspofungin in a Persistently Neutropenic Murine Model of Disseminated Aspergillosis (click for details)


Subscribe to ICAAC 45th